Symbolbild · KI-generiert
Sharp Therapeutics Corp.
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.
Company profile
Sharp Therapeutics is a preclinical-stage company developing first-choice small-molecule therapeutics for genetic diseases. The Company's discovery platform combines novel high throughput screening technologies, with compound libraries computational optimized based on the physics and biology of cellular trafficking defects and allosteric activation of proteins. The platform produces small molecule compounds that restore activity in mutated proteins giving the potential to treat genetic disorders with conventional pill-based medicines.
Company description as published by the issuer via TMX Money.
Comparable companies
Companies in the Biotech & Pharma sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| Sharp Therapeutics Corp. | SHRX | TSXV | 20 Mio. USD |
| EnWave Corporation | ENW | TSXV | 20 Mio. USD |
| Devonian Health Group Inc. | GSD | TSXV | 20 Mio. USD |
| Voyageur Pharmaceuticals Ltd. | VM | TSXV | 21 Mio. USD |
| Mountain Valley MD Holdings Inc. | MVMD | CSE | 19 Mio. USD |
| Rubicon Organics Inc. | ROMJ | TSXV | 23 Mio. USD |
| Illumisoft Lighting Corp. | UVC | TSXV | 23 Mio. USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.